BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

353 related articles for article (PubMed ID: 11102289)

  • 1. Determination of monomethylarsonous acid, a key arsenic methylation intermediate, in human urine.
    Le XC; Ma M; Cullen WR; Aposhian HV; Lu X; Zheng B
    Environ Health Perspect; 2000 Nov; 108(11):1015-8. PubMed ID: 11102289
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Determination of arsenic metabolic complex excreted in human urine after administration of sodium 2,3-dimercapto-1-propane sulfonate.
    Gong Z; Jiang G; Cullen WR; Aposhian HV; Le XC
    Chem Res Toxicol; 2002 Oct; 15(10):1318-23. PubMed ID: 12387631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Identification of dimethylarsinous and monomethylarsonous acids in human urine of the arsenic-affected areas in West Bengal, India.
    Mandal BK; Ogra Y; Suzuki KT
    Chem Res Toxicol; 2001 Apr; 14(4):371-8. PubMed ID: 11304125
    [TBL] [Abstract][Full Text] [Related]  

  • 4. DMPS-arsenic challenge test. II. Modulation of arsenic species, including monomethylarsonous acid (MMA(III)), excreted in human urine.
    Aposhian HV; Zheng B; Aposhian MM; Le XC; Cebrian ME; Cullen W; Zakharyan RA; Ma M; Dart RC; Cheng Z; Andrewes P; Yip L; O'Malley GF; Maiorino RM; Van Voorhies W; Healy SM; Titcomb A
    Toxicol Appl Pharmacol; 2000 May; 165(1):74-83. PubMed ID: 10814555
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arsenic speciation in urine from acute promyelocytic leukemia patients undergoing arsenic trioxide treatment.
    Wang Z; Zhou J; Lu X; Gong Z; Le XC
    Chem Res Toxicol; 2004 Jan; 17(1):95-103. PubMed ID: 14727923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Speciation of key arsenic metabolic intermediates in human urine.
    Le XC; Lu X; Ma M; Cullen WR; Aposhian HV; Zheng B
    Anal Chem; 2000 Nov; 72(21):5172-7. PubMed ID: 11080860
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Speciation of arsenic in biological samples.
    Mandal BK; Ogra Y; Anzai K; Suzuki KT
    Toxicol Appl Pharmacol; 2004 Aug; 198(3):307-18. PubMed ID: 15276410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel pathway for arsenic elimination: human multidrug resistance protein 4 (MRP4/ABCC4) mediates cellular export of dimethylarsinic acid (DMAV) and the diglutathione conjugate of monomethylarsonous acid (MMAIII).
    Banerjee M; Carew MW; Roggenbeck BA; Whitlock BD; Naranmandura H; Le XC; Leslie EM
    Mol Pharmacol; 2014 Aug; 86(2):168-79. PubMed ID: 24870404
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue dosimetry, metabolism and excretion of pentavalent and trivalent monomethylated arsenic in mice after oral administration.
    Hughes MF; Devesa V; Adair BM; Styblo M; Kenyon EM; Thomas DJ
    Toxicol Appl Pharmacol; 2005 Oct; 208(2):186-97. PubMed ID: 16183392
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uptake of inorganic and organic derivatives of arsenic associated with induced cytotoxic and genotoxic effects in Chinese hamster ovary (CHO) cells.
    Dopp E; Hartmann LM; Florea AM; von Recklinghausen U; Pieper R; Shokouhi B; Rettenmeier AW; Hirner AV; Obe G
    Toxicol Appl Pharmacol; 2004 Dec; 201(2):156-65. PubMed ID: 15541755
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Monomethylarsonous acid (MMA(III)) is more toxic than arsenite in Chang human hepatocytes.
    Petrick JS; Ayala-Fierro F; Cullen WR; Carter DE; Vasken Aposhian H
    Toxicol Appl Pharmacol; 2000 Mar; 163(2):203-7. PubMed ID: 10698679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Occurrence of monomethylarsonous acid in urine of humans exposed to inorganic arsenic.
    Aposhian HV; Gurzau ES; Le XC; Gurzau A; Healy SM; Lu X; Ma M; Yip L; Zakharyan RA; Maiorino RM; Dart RC; Tircus MG; Gonzalez-Ramirez D; Morgan DL; Avram D; Aposhian MM
    Chem Res Toxicol; 2000 Aug; 13(8):693-7. PubMed ID: 10956055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of arsenic in foodstuffs on the people living in the arsenic-affected areas of West Bengal, India.
    Mandal BK; Suzuki KT; Anzai K
    J Environ Sci Health A Tox Hazard Subst Environ Eng; 2007 Oct; 42(12):1741-52. PubMed ID: 17952775
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Arsenic speciation and identification of monomethylarsonous acid and monomethylthioarsonic acid in a complex matrix.
    Yathavakilla SK; Fricke M; Creed PA; Heitkemper DT; Shockey NV; Schwegel C; Caruso JA; Creed JT
    Anal Chem; 2008 Feb; 80(3):775-82. PubMed ID: 18181583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Urinary arsenic methylation capability and carotid atherosclerosis risk in subjects living in arsenicosis-hyperendemic areas in southwestern Taiwan.
    Huang YL; Hsueh YM; Huang YK; Yip PK; Yang MH; Chen CJ
    Sci Total Environ; 2009 Apr; 407(8):2608-14. PubMed ID: 19187952
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A review of the enzymology of arsenic metabolism and a new potential role of hydrogen peroxide in the detoxication of the trivalent arsenic species.
    Aposhian HV; Zakharyan RA; Avram MD; Sampayo-Reyes A; Wollenberg ML
    Toxicol Appl Pharmacol; 2004 Aug; 198(3):327-35. PubMed ID: 15276412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Arsenic species excretion after dimercaptopropanesulfonic acid (DMPS) treatment of an acute arsenic trioxide poisoning.
    Heinrich-Ramm R; Schaller H; Horn J; Angerer J
    Arch Toxicol; 2003 Feb; 77(2):63-8. PubMed ID: 12590357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DMPS-arsenic challenge test. I: Increased urinary excretion of monomethylarsonic acid in humans given dimercaptopropane sulfonate.
    Aposhian HV; Arroyo A; Cebrian ME; del Razo LM; Hurlbut KM; Dart RC; Gonzalez-Ramirez D; Kreppel H; Speisky H; Smith A; Gonsebatt ME; Ostrosky-Wegman P; Aposhian MM
    J Pharmacol Exp Ther; 1997 Jul; 282(1):192-200. PubMed ID: 9223554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The accumulation and toxicity of methylated arsenicals in endothelial cells: important roles of thiol compounds.
    Hirano S; Kobayashi Y; Cui X; Kanno S; Hayakawa T; Shraim A
    Toxicol Appl Pharmacol; 2004 Aug; 198(3):458-67. PubMed ID: 15276427
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Speciation of arsenic metabolite intermediates in human urine by ion-exchange chromatography and flow injection hydride generation atomic absorption spectrometry.
    Alauddin M; Alauddin ST; Bhattacharjee M; Sultana S; Chowdhury D; Bibi H; Rabbani GH
    J Environ Sci Health A Tox Hazard Subst Environ Eng; 2003 Jan; 38(1):115-28. PubMed ID: 12635822
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.